The approval expands the indication for Amvuttra, which now becomes the first and only therapeutic approved by the FDA for ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

Learn how ultrafine bubble showers can improve eczema symptoms by reducing inflammation and enhancing skin barrier proteins.

Recent advancements in endometriosis research are transforming treatment, focusing on non-surgical interventions and ...

Aiforia and Techcyte announce strategic collaboration to advance AI-powered digital pathology Aiforia Technologies Plc, Press Release, March 21, 2025 at 09:00 a.m. EET Aiforia, a trusted provider of d ...

Ovarian cancer (OC) is the fifth most common cause of cancer-related mortality worldwide and represents the leading cause of death for gynecological malignancies. Nevertheless, over the last years, ...

Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical ...

Although the regulatory landscape for advanced therapy medicinal products (ATMPs) is rapidly evolving, varying regulatory ...

Investing.com -- Alnylam Pharmaceuticals (NASDAQ: NASDAQ: ALNY) stock climbed 5% as trading resumed on Friday morning, following the company’s announcement that the FDA has approved AMVUTTRA for ...

Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.